imiquimod has been researched along with everolimus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| De Meyer, GR; De Meyer, I; Martinet, W; Schrijvers, DM; Timmermans, JP; Verheye, S | 1 |
| Fujita, T; Hamano, I; Hashimoto, Y; Hatakeyama, S; Imai, A; Koie, T; Murakami, R; Narumi, S; Ohyama, C; Saitoh, H; Shimada, M; Suzuki, T; Tomita, H; Yamamoto, H; Yoneyama, T | 1 |
1 review(s) available for imiquimod and everolimus
| Article | Year |
|---|---|
Drug-induced macrophage autophagy in atherosclerosis: for better or worse?
Topics: Aminoquinolines; Animals; Autophagy; Cytokines; Everolimus; Humans; Imiquimod; Macrophages; Mice; Plaque, Atherosclerotic; Sirolimus; Toll-Like Receptor 7; TOR Serine-Threonine Kinases | 2013 |
2 other study(ies) available for imiquimod and everolimus
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Condyloma Acuminata of the Urethra in a Male Renal Transplant Recipient: A Case Report.
Topics: Adult; Condylomata Acuminata; Everolimus; Humans; Imiquimod; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Tacrolimus; Transplant Recipients; Urethral Diseases | 2018 |